Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?

Clinical Infectious Diseases

Volumn 49, Issue 4, 2009, Pages 588-590

  Birkebaek, Niels H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

EPIDEMIC; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; NOTE; PERTUSSIS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; FEMALE; HEALTH PERSONNEL; HOSPITALS; HUMANS; IMMUNIZATION, SECONDARY; MALE; WHOOPING COUGH;

EID: 67651121489     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/603556     Document Type: Note

References (13)

1. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 24:S44-7.
2. Birkebaek NH, Kristiansen M, Seefeldt T, et al. Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999; 29:1239-42.
3. Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008; 21:426-34.
4. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota 1995-1996. J Infect Dis 2001; 183:1353-9.
5. Ward JI, Cherry JC, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353: 1555-63.
6. Wendelboe AaM, Van Rie A, Salmaso S, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:S58-61.
7. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Pediatr Respir Rev 2008; 9:201-11.
8. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367:1926-36.
9. Linnemann CC, Ramundo N, Perlstein PH, et al. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975; 2:540-3.
10. Leekha S, Thompson RL, Sampathkumar P. Epidemiology and control of pertussis outbreaks in a tertiary care center and the resource consumption associated with these outbreaks. Infect Control Hosp Epidemiol 2009; 30:467-73.
11. Kretsinger K, Broder KR, Cortese MM, et al. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults:use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Rec- omm Rep 2006;55(RR-17):1-37.
12. Halperin SA, Smith B, Russell M, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents ad adults. Vaccine 2000; 18:1312-9.
13. Kirkland KB, Talbot EA, Decker MD, Edwards KM. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control. Clin Infect Dis 2009;49: 584-7 (in this issue).